Pune, India, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The global digital pathology market size was valued at USD 798.8 million in 2021 and touched USD 892.5 million in 2022. The market is expected to reach USD 2,045.9 million by 2029, exhibiting a CAGR of 12.6% during the forecast period. Rising awareness of novel diagnostics and the increasing prevalence of chronic disorders are likely to incite market growth. Fortune Business Insights™ shares this information in its report titled “Digital Pathology Market, 2022-2029.”
Key Industry Development
- March 2022 – Thermo Fisher Scientific, Inc. launched CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform for use in clinical laboratories and to perform both diagnostic and clinical research.
- April 2022- 3DHISTECH Ltd. entered into an agreement with the Catalan Health Institute (ICS). This strategy was undertaken for the deployment of digital tools for pathology within a network of 8 hospitals.
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pathology-market-100229
Report Coverage
The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market's key players.
Report Scope:
| Report Coverage | Details |
| Forecast Period | 2022 to 2029 |
| Forecast Period 2022 to 2029 CAGR | 12.6% |
| 2029 Value Projection | 2,045.9 Million |
| Base Year | 2021 |
| Market Size in 2022 | USD 892.5 Million |
| Historical Data for | 2018 to 2020 |
| No. of Pages | 149 |
Driving Factors
Strong Approvals for Digital Tools May Foster Market Growth
Digital pathology is a digital tool that collects, analyzes, and interprets pathology information. The increasing approvals for digital tools may bolster the product demand. Rising chronic disorders and exponential procedure adoption may enhance the services’ adoption. Further, increasing applications of the service boosted industry growth. Also, strong demand for drug discovery utilizing high-throughput applications may enhance the product adoption. In addition, the introduction of digitizing pathology may incite the services’ demand. These factors may drive the digital pathology market growth.
However, the services’ high upfront installation costs may hamper the market’s progress.
Click here to get the short-term and long-term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/digital-pathology-market-100229
Segmentation
Hardware Segment May Hold a Dominant Market Share Owing to Strong Demand for Time-Efficient Pathology Outcomes
By product, the market is segmented into hardware, software, and storage systems.
The hardware segment may dominate due to the strong demand for time-efficient pathology outcomes. Moreover, companies focus extensively on satisfying pathology and diagnostics demand, thereby elevating market progress.
Drug Discovery Segment to Dominate Because of the Strong Demand for Potential Pipeline Drugs
Based on application, the market is trifurcated into disease diagnosis, drug discovery, and others.
The drug discovery segment may dominate the market share due to the strong adoption of potential pipeline drugs. Further, rising awareness regarding precautionary pathology may propel segmental growth.
Hospitals & Clinics Segment to Dominate Market Share Owing to Strong Hospital Admissions
As per end-user, the market is categorized into hospitals & clinics, clinical laboratories, and others.
The hospitals & clinics segment is expected to dominate the market share due to rising hospital admissions. Also, strategic collaborations to launch advanced products may bolster market progress.
Geographically, the market is clubbed into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
| Digital Pathology Market Segmentation | By Product
|
By Application
| |
By End-user
|
Quick Buy - Digital Pathology Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100229
COVID-19 Impact:
Strong Demand for Healthcare Devices Fostered Market’s Progress
This industry was positively impacted during the COVID-19 pandemic due to strong demand for healthcare devices. Increasing cases of chronic disorders generated massive demand for pathology tools, thereby enhancing sales. Furthermore, increasing government initiatives promoting the adoption of virtual treatment procedures for the coronavirus improved the product’s adoption. Moreover, the expansion of virtual education allowed healthcare physicians to aid patients using virtual means. For example, the Centers for Medicare & Medicaid Services (CMS) declared regulatory changes to transform medical services. It allowed patients in the U.S. to achieve efficient medical treatment. These factors propelled industry growth during the pandemic.
Regional Insights
Increasing Aged Population May Boost Industry Growth in North America
North America is anticipated to dominate the digital pathology market share due to the rising aged population. The market in North America stood at USD 280.6 million in 2021 and may likely to grow positively in the upcoming years. Further, strong demand for workload streamlining may elevate the market growth.
In Europe, consumers' rising preference for digital tools surged the demand for digital pathology. Further, increasing the adoption of technologically advanced products is likely to bolster market growth.
In Asia Pacific, increasing partnerships between healthcare companies and chains may enhance the adoption of virtual pathology services. Further, robust investments in private and public institutions may bolster the industry’s growth.
Competitive Landscape
Crucial Players Partner with Key Players to Expand Market Presence
The prominent companies operating in the market partner with crucial players to expand their market presence. For example, Leica Biosystems Nussloch GmbH partnered with Leap Therapeutics in January 2022. This development was aimed at developing companion diagnostics for Dickkopfrelated protein 1 (DKK1) and Leap Therapeutics’ anti-DKK1 cancer therapy. This strategy may also allow the company to expand its market presence. Further, companies devise mergers, expansions, novel product launches, research and development, and innovations to bolster their market position.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/digital-pathology-market-100229
List of Key Players Profiled in the Digital Pathology Market Report:
- Thermo Fisher Scientific Inc. (U.S.)
- Hoffmann-La Roche Ltd. (Switzerland)
- Hamamatsu Photonics K.K. (Japan)
- 3DHISTECH Ltd. (Hungary)
- Koninklijke Philips N.V. (Netherland)
- Apollo Enterprise Imaging Corp (U.S.)
- Sectra AB (Sweden)
- Huron Technologies International Inc. (Canada)
Table of Content
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments- Mergers, Acquisitions and Partnerships
- Technological Advancements in Digital Pathology
- Snapshot: Global Digital Health Market, 2021
- Impact of COVID-19 on the Market
- Global Digital Pathology Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Product
- Hardware
- Market Analysis, Insights and Forecast – By Product
-
-
-
- Scanners
- Tissue Microarrayer
- Others
-
-
-
-
- Software
-
-
-
-
- Pathology Management
- Digital Microscopy Viewers
- Image Analyzers
- Others
-
-
- North America Digital Pathology Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Product
- Hardware
- Market Analysis, Insights and Forecast – By Product
-
- Market Analysis, Insights and Forecast – By Application
- Disease Diagnosis
- Drug Discovery
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospitals & Clinics
- Clinical Laboratories
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
-
- Storage Systems
- Market Analysis, Insights and Forecast – By Application
-
-
-
- Scanners
- Tissue Microarrayer
- Others
-
-
-
-
- Software
-
-
-
-
- Pathology Management
- Digital Microscopy Viewers
- Image Analyzers
- Others
-
-
- Europe Digital Pathology Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Product
- Hardware
- Market Analysis, Insights and Forecast – By Product
-
- Market Analysis, Insights and Forecast – By Application
- Disease Diagnosis
- Drug Discovery
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospitals & Clinics
- Clinical Laboratories
- Others
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
-
- Storage Systems
- Market Analysis, Insights and Forecast – By Application
-
-
-
- Scanners
- Tissue Microarrayer
- Others
-
-
- Asia Pacific Digital Pathology Market Analysis, Insights and Forecast, 2018-2029
- Latin America Digital Pathology Market Analysis, Insights and Forecast, 2018-2029
- Middle East & Africa Digital Pathology Market Analysis, Insights and Forecast, 2018-2029
- Competitive Analysis
-
- Market Analysis, Insights and Forecast – By Application
- Disease Diagnosis
- Drug Discovery
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospitals & Clinics
- Clinical Laboratories
- Others
- Market Analysis, Insights and Forecast – By Country/ Sub-region
-
- Software
- Storage Systems
- Market Analysis, Insights and Forecast – By Application
-
- Global Market Share Analysis (2021)
- Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
- Leica Biosystems Nussloch GmbH
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Hamamatsu Photonics K.K.
- Akoya Biosciences, Inc.
- 3DHISTECH Ltd.
- Koninklijke Philips N.V.
- Apollo Enterprise Imaging Corp
- Sectra AB
- Huron Technologies International Inc.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/digital-pathology-market-100229
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them in addressing various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S. :+1 424 253 0390
U.K. : +44 2071 939123
APAC : +91 744 740 1245
